Difference between revisions of "LINC02055"
Guangyu Wang (talk | contribs) (Created page with "==Annotated Information== ===Approved Symbol=== LINC02055 ===Approved Name=== long intergenic non-protein coding RNA 2055 ===Previous Symbols=== _ ===Synonyms=== RP1130-1 ===C...") |
Jiabao Cao (talk | contribs) |
||
| Line 1: | Line 1: | ||
| + | |||
==Annotated Information== | ==Annotated Information== | ||
| − | === | + | ===Name=== |
| − | LINC02055 | + | LINC02055:long intergenic non-protein coding RNA 2055 |
| − | + | ||
| − | long intergenic non-protein coding RNA 2055 | + | RP1130-1<ref name="ref1" /> |
| − | = | + | ===Function=== |
| − | + | [[ | |
| − | === | + | LINC RP1130-1 expression is correlated with clinical stage, the number of tumors, PVTT, liver cirrhosis, and microvascular invasion in patients with HCC(human hepatocellular carcinoma). More importantly, patients with a low level of LINC RP1130-1 expression has a shorter recurrence-free survival(RFS) than those with a high level of LINC RP1130-1 expression.<ref name="ref1" /> |
| − | RP1130-1 | + | |
| − | === | + | ===Expression=== |
| − | + | [[ | |
| − | === | + | The level of LINC RP1130-1 expression decreases significantly in HCC(human hepatocellular carcinoma) relative to that in adjacent non-tumor tissues. <ref name="ref1" /> |
| − | + | ===Diseases=== | |
| − | === | + | Human hepatocellular carcinoma<ref name="ref1" /> |
| − | + | ===Sequence=== | |
| − | === | + | >XR_001746102.1 PREDICTED: Homo sapiens uncharacterized LOC107986980 (LOC107986980), transcript variant X1, ncRNA |
| − | + | <dnaseq>GGGAGCCCAGGCAGAGGAGGCGCCCAGAGCGAGCGAGGGCTGTGAGGACTGCCAGCACGCTGTCACCTCT | |
| − | = | + | CACTCATATAGATTGCCAATCTATTTGTGAACCAGGTTTGCTGGAGTTTGGATTTACTACTGAGTCATAT |
| − | + | TTGGAGCATGCTGGAATCTTACAACTGAGATTACCGAGTCAGAAACTTGCAAACATGAGTAACATGGCCC | |
| + | TGCTCTGGAGACTACTGGGAACACAAACACAGCCATTTAAGACATCTACCTGCTTCTCCTTTGCCTTCCA | ||
| + | TCATGACTGAAAGTTGTCTGAGGTCTCCCAGCCACGTGTCCTGTACAGCCTGTGGAACTACTTTAAAGAA | ||
| + | GAATCAGAAAATGGAGACTGGGATTGGAAGCAGAGATCCGATGGCCAAATTACAGTCTGCCACTGAAGCT | ||
| + | AACACACCTATGGATAACCCAACCTGTAAACTCAATGTGGAACACAGTTTGAGAAAAGAAGTGAGAAGAT | ||
| + | TCAATTTTGAAGTTGGATCACTCTCCTACAGGCAATGAAGACCACATCACTGATGGCTCTCCTGCAATTC | ||
| + | TATTACCTGTTTGAATGTGAAGATGGGATGAAGTAGCAAGAAGGACCTCACAAAATACCTCCCCCACCAC | ||
| + | CCCATCATCTTGCACTTTCCAGTCTGCAGAACTGTGAGAA | ||
| + | </dnaseq> | ||
| + | |||
| + | ==Labs working on this lncRNA== | ||
| + | *Departments of Surgical Oncology, Chinese People's Liberation Army (PLA) General Hospital. | ||
| + | ==References== | ||
| + | <references> | ||
| + | <ref name="ref1"> | ||
| + | Xiao C, Wang C, Cheng S, Lai C, Zhang P, Wang Z, Zhang T, Zhang S, Liu R. The | ||
| + | significance of low levels of LINC RP1130-1 expression in human hepatocellular | ||
| + | carcinoma. Biosci Trends. 2016 Nov 15;10(5):378-385. | ||
| + | </ref> | ||
| + | </references> | ||
Revision as of 11:52, 23 November 2017
Contents
Annotated Information
Name
LINC02055:long intergenic non-protein coding RNA 2055
RP1130-1[1]
Function
[[ LINC RP1130-1 expression is correlated with clinical stage, the number of tumors, PVTT, liver cirrhosis, and microvascular invasion in patients with HCC(human hepatocellular carcinoma). More importantly, patients with a low level of LINC RP1130-1 expression has a shorter recurrence-free survival(RFS) than those with a high level of LINC RP1130-1 expression.[1]
Expression
[[ The level of LINC RP1130-1 expression decreases significantly in HCC(human hepatocellular carcinoma) relative to that in adjacent non-tumor tissues. [1]
Diseases
Human hepatocellular carcinoma[1]
Sequence
>XR_001746102.1 PREDICTED: Homo sapiens uncharacterized LOC107986980 (LOC107986980), transcript variant X1, ncRNA
000001 GGGAGCCCAG GCAGAGGAGG CGCCCAGAGC GAGCGAGGGC TGTGAGGACT GCCAGCACGC TGTCACCTCT CACTCATATA 000080
000081 GATTGCCAAT CTATTTGTGA ACCAGGTTTG CTGGAGTTTG GATTTACTAC TGAGTCATAT TTGGAGCATG CTGGAATCTT 000160
000161 ACAACTGAGA TTACCGAGTC AGAAACTTGC AAACATGAGT AACATGGCCC TGCTCTGGAG ACTACTGGGA ACACAAACAC 000240
000241 AGCCATTTAA GACATCTACC TGCTTCTCCT TTGCCTTCCA TCATGACTGA AAGTTGTCTG AGGTCTCCCA GCCACGTGTC 000320
000321 CTGTACAGCC TGTGGAACTA CTTTAAAGAA GAATCAGAAA ATGGAGACTG GGATTGGAAG CAGAGATCCG ATGGCCAAAT 000400
000401 TACAGTCTGC CACTGAAGCT AACACACCTA TGGATAACCC AACCTGTAAA CTCAATGTGG AACACAGTTT GAGAAAAGAA 000480
000481 GTGAGAAGAT TCAATTTTGA AGTTGGATCA CTCTCCTACA GGCAATGAAG ACCACATCAC TGATGGCTCT CCTGCAATTC 000560
000561 TATTACCTGT TTGAATGTGA AGATGGGATG AAGTAGCAAG AAGGACCTCA CAAAATACCT CCCCCACCAC CCCATCATCT 000640
000641 TGCACTTTCC AGTCTGCAGA ACTGTGAGAA
000081 GATTGCCAAT CTATTTGTGA ACCAGGTTTG CTGGAGTTTG GATTTACTAC TGAGTCATAT TTGGAGCATG CTGGAATCTT 000160
000161 ACAACTGAGA TTACCGAGTC AGAAACTTGC AAACATGAGT AACATGGCCC TGCTCTGGAG ACTACTGGGA ACACAAACAC 000240
000241 AGCCATTTAA GACATCTACC TGCTTCTCCT TTGCCTTCCA TCATGACTGA AAGTTGTCTG AGGTCTCCCA GCCACGTGTC 000320
000321 CTGTACAGCC TGTGGAACTA CTTTAAAGAA GAATCAGAAA ATGGAGACTG GGATTGGAAG CAGAGATCCG ATGGCCAAAT 000400
000401 TACAGTCTGC CACTGAAGCT AACACACCTA TGGATAACCC AACCTGTAAA CTCAATGTGG AACACAGTTT GAGAAAAGAA 000480
000481 GTGAGAAGAT TCAATTTTGA AGTTGGATCA CTCTCCTACA GGCAATGAAG ACCACATCAC TGATGGCTCT CCTGCAATTC 000560
000561 TATTACCTGT TTGAATGTGA AGATGGGATG AAGTAGCAAG AAGGACCTCA CAAAATACCT CCCCCACCAC CCCATCATCT 000640
000641 TGCACTTTCC AGTCTGCAGA ACTGTGAGAA
Labs working on this lncRNA
- Departments of Surgical Oncology, Chinese People's Liberation Army (PLA) General Hospital.
